Breast Cancer Market Analysis by Therapy (Hormonal Therapy, Targeted Therapy, Surgery and radiation therapy, Biologic therapy), By Cancer Type (Hormone Receptor, HER2+), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others) and by Region: Global Forecast, 2024 - 2034
- PUBLISHED ON
- 2024-04-17
- NO OF PAGES
- 191
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Breast Cancer market is predicted to develop at a compound annual growth rate (CAGR) of 10% from 2024 to 2034, when it is projected to reach USD 73.21 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 31.2 Billion in 2024.
SOURCE: We Market Research
A malignant
growth that starts in the breast tissue, usually in the lobules or milk ducts,
is called breast cancer. It is the most prevalent type of cancer in women
globally. Breast lumps, nipple discharge, changes in skin texture or shape, and
breast soreness are some of the symptoms. Hormonal effects, genetics, and
lifestyle decisions are risk factors. For successful therapy, early diagnosis
through screenings like mammograms is essential. Treatment choices include surgery,
radiation, chemotherapy, hormone treatment, and targeted therapy, depending on
the kind and stage of the cancer. Survival rates have increased as a result of
increased knowledge and study, highlighting the significance of routine
checkups and self-examinations.
Research,
therapy, and market dynamics are shaped by a number of factors that influence
the breast cancer market. Targeted medicines and customized medicine are being
made possible by ongoing advances in genetic and molecular research. A stronger
focus on early detection via genetic testing and mammography screening programs
is improving patient outcomes. The demand for cutting-edge therapies and
diagnostic tools is being driven by rising incidence rates worldwide. Survival
rates are rising as a result of the emergence of innovative therapeutics
including immunotherapy and combination therapies. Strong patient advocacy
initiatives, research funding, and supportive government regulations all help
the breast cancer market expand and thrive, which eventually benefits both patients
and healthcare systems.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD 31.2 Billion |
|
Market Forecast in 2034 |
USD 73.21Billion |
|
CAGR % 2024-2034 |
10% |
|
Base Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast Period |
2024-2034 |
|
Report USP
|
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
By Therapy, By Cancer Type, By Distribution Channel and By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Breast Cancer Industry: Dynamics & Restrains
Market opportunity:
We Market Research: Breast Cancer Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Breast Cancer Segmentation
Market- By Therapy Analysis
By Therapy, the Breast Cancer Market is Categories into Hormonal Therapy, Targeted Therapy, Surgery and radiation therapy, Biologic therapy. The Targeted Therapy is the segment accounts for the largest share of around 79% in 2024.
Personalized care, exact efficacy against
certain molecular targets, less side effects, breakthroughs in biomarkers for
patient selection, advantages of combination therapy, and continuous innovation
are the driving forces behind targeted therapy in breast cancer. This strategy
improves results by providing personalized, efficient cancer care.
The
following segments are part of an in-depth analysis of the global Breast Cancer
market:
|
Market Segments |
|
|
By Cancer
Type |
·
Hormone Receptor ·
HER2+ |
|
By Distribution
Channel |
·
Retail Pharmacies ·
Hospital Pharmacies ·
Online Pharmacies ·
Others |
Breast Cancer Industry: Regional Analysis
North America Market Forecast
North America dominate the Breast Cancer Market with the highest revenue generating market with share of more than 48%. The Breast Cancer market in North America thrives due to the high prevalence of breast cancer, advanced healthcare infrastructure, early adoption of novel therapies, robust research and development activities, favorable reimbursement policies, and increasing awareness among patients and healthcare providers.
Europe Market Statistics
Europe is second
largest region in Breast Cancer market due to the growing incidence of breast
cancer, emphasis on personalized medicine, supportive regulatory environment
for drug approvals, strong investments in healthcare, presence of leading
pharmaceutical companies, and collaborative research initiatives.
Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Breast Cancer market
during the forecast period. In the Asia Pacific region, rising awareness about
breast cancer screening, improving healthcare access in developing countries,
increasing disposable income, expanding investments in healthcare
infrastructure, emergence of local pharmaceutical industries, and government
initiatives to tackle cancer.
Key Market Players
The Breast
Cancer Market is dominated by a few large companies, such as
·
Merck & Co
·
AstraZeneca
·
Novartis AG
·
Eli Lilly and Company
·
GlaxoSmithKline
·
Sanofi
·
Pfizer Inc
·
Genentech
· Mylan Laboratories
· Other
1.
Global
Breast Cancer Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Breast Cancer Market
Scope and Market Estimation
1.2.1. Global Breast Cancer Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Breast Cancer Market
Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1. Component of Global Breast
Cancer Market
1.3.2. Technology of Global Breast
Cancer Market
1.3.3. Distribution Channel of Global Breast Cancer Market
1.3.4. Region of Global Breast Cancer
Market
2.
Executive Summary
2.1. Global Breast Cancer Market Industry Trends under COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Breast Cancer Market
Industry Development
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5. Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6. Value Chain / Ecosystem Analysis
2.7. Russia-Ukraine War Impacts
Analysis
2.8. Economic Downturn Analysis
2.9. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Breast Cancer Market Estimates & Historical Trend Analysis (2019 -
2023)
4.
Global Breast Cancer Market Estimates & Forecast Trend Analysis, by
THERAPY
4.1. Global Breast Cancer Market
Revenue (US$ Mn) Estimates and Forecasts, by THERAPY, 2019 to 2034
4.1.1. Hormonal Therapy
4.1.2. Targeted Therapy
4.1.3. Surgery and radiation therapy
4.1.4. Biologic therapy
5.
Global Breast Cancer Market Estimates & Forecast Trend Analysis, by
Cancer Type
5.1. Global Breast Cancer Market
Revenue (US$ Mn) Estimates and Forecasts, by Cancer Type, 2019 to 2034
5.1.1. Hormone Receptor
5.1.2. HER2+
6.
Global Breast Cancer Market Estimates & Forecast Trend Analysis, by
Distribution Channel
6.1. Global Breast Cancer Market
Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel ,
2019 to 2034
6.1.1. Retail Pharmacies
6.1.2. Hospital Pharmacies
6.1.3. Online Pharmacies
6.1.4. Others
7.
Global Breast Cancer Market Estimates & Forecast Trend Analysis,
by Region
7.1. Global Breast Cancer Market
Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Middle East & Africa
7.1.5. South America
8.
North
America Breast Cancer Market: Estimates & Forecast Trend Analysis
8.1.
North
America Breast Cancer Market Assessments & Key Findings
8.1.1. North America Breast Cancer
Market Introduction
8.1.2. North America Breast Cancer
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
8.1.2.1. By THERAPY
8.1.2.2. By Cancer Type
8.1.2.3. By Distribution
Channel
8.1.2.4. By Country
8.1.2.4.1. The U.S.
8.1.2.4.2. Canada
8.1.2.4.3. Mexico
9.
Europe
Breast Cancer Market: Estimates & Forecast Trend Analysis
9.1. Europe Breast Cancer Market
Assessments & Key Findings
9.1.1. Europe Breast Cancer Market
Introduction
9.1.2. Europe Breast Cancer Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1. By THERAPY
9.1.2.2. By Cancer Type
9.1.2.3. By Distribution
Channel
9.1.2.4.
By
Country
9.1.2.4.1. Germany
9.1.2.4.2. U.K.
9.1.2.4.3. France
9.1.2.4.4. Italy
9.1.2.4.5. Spain
9.1.2.4.6. Russia
9.1.2.4.7. Rest of Europe
10. Asia Pacific Breast
Cancer Market: Estimates & Forecast
Trend Analysis
10.1. Asia Pacific Market Assessments
& Key Findings
10.1.1. Asia Pacific Breast Cancer
Market Introduction
10.1.2. Asia Pacific Breast Cancer
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1. By THERAPY
10.1.2.2. By Cancer Type
10.1.2.3. By Distribution
Channel
10.1.2.4. By Country
10.1.2.4.1. China
10.1.2.4.2. Japan
10.1.2.4.3. India
10.1.2.4.4. Australia
10.1.2.4.5. South Korea
10.1.2.4.6. ASEAN
10.1.2.4.7. Rest of Asia Pacific
11. Middle East & Africa Breast
Cancer Market: Estimates & Forecast
Trend Analysis
11.1. Middle East & Africa Market
Assessments & Key Findings
11.1.1. Middle
East & Africa Breast
Cancer Market Introduction
11.1.2. Middle
East & Africa Breast
Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1. By THERAPY
11.1.2.2. By Cancer Type
11.1.2.3. By Distribution
Channel
11.1.2.4. By Country
11.1.2.4.1. U.A.E.
11.1.2.4.2. Saudi Arabia
11.1.2.4.3. Egypt
11.1.2.4.4. South Africa
11.1.2.4.5. Rest of Middle East & Africa
12. South America
Breast Cancer Market: Estimates &
Forecast Trend Analysis
12.1. South America Market Assessments
& Key Findings
12.1.1. South America Breast Cancer
Market Introduction
12.1.2. South America Breast Cancer
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1. By THERAPY
12.1.2.2. By Cancer Type
12.1.2.3. By Distribution
Channel
12.1.2.4. By Country
12.1.2.4.1. Brazil
12.1.2.4.2. Argentina
12.1.2.4.3. Colombia
12.1.2.4.4. Rest of South America
13. Competition Landscape
13.1. Global Breast Cancer Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
13.2. Global Breast Cancer Market
Competition White Space Analysis, By Distribution Channel
13.3. Global Breast Cancer Market
Competition Heat Map Analysis, By Distribution Channel
13.4. Global Breast Cancer Market
Concentration & Company Market Shares (%) Analysis, 2022
14. Company Profiles
14.1.
Merck & Co.
14.1.1. Company Overview & Key Stats
14.1.2. Financial Performance & KPIs
14.1.3. Product Portfolio
14.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
14.2. AstraZeneca
14.3. Novartis AG
14.4. Eli Lilly and
Company
14.5. GlaxoSmithKline
14.6. Sanofi
14.7. Pfizer Inc
14.8. Genentech
14.9. Mylan
Laboratories
14.10. Others
15. Research
Methodology
15.1. External Transportations /
Databases
15.2. Internal Proprietary Database
15.3. Primary Research
15.4. Secondary Research
15.5. Assumptions
15.6. Limitations
15.7. Report FAQs
16. Research Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Breast Cancer Market in 2024?
Breast Cancer Market was valued at USD 31.2 Billion in 2024.
What is the growth rate for the Breast Cancer Market?
Breast Cancer Market size will increase at approximate CAGR of 10% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Breast Cancer Market Are Merck & Co, AstraZeneca, Novartis AG, Eli Lilly and Company, GlaxoSmithKline, Sanofi, Pfizer Inc, Genentech, Mylan Laboratories and Others.
Which region dominates the Breast Cancer Market?
North America dominates the market with an active share of 48%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI